Anne-Marie Landtblom
Professor emeritus vid Institutionen för medicinska vetenskaper; Neurologi
- Telefon:
- 018-611 50 31
- Mobiltelefon:
- 070-559 16 70
- E-post:
- anne-marie.landtblom@neuro.uu.se
- Besöksadress:
- Akademiska sjukhuset
- Postadress:
- Akademiska sjukhuset, ing 85 plan 2
751 85 UPPSALA
- Akademiska meriter:
- MD PhD
Mer information visas för dig som medarbetare om du loggar in.
Kort presentation
Professor emeritus i neurologi med specaliteter MS, sömnsjukdomar och epilepsi. Verksam även vid Hälsouniversitetet i Östergötland inkl. CMIV, bildmedicinskt center, med fokus på imaging särskilt magnetkameraforskning av narkolepsi, Kleine Levin syndrom (KLS), epilepsi och MS. Aktiviteter i kvalitetsregister: Svenska neuroregistret, i första hand Svenska narkolepsiregistret. Epidemiologisk forskning, särskilt om MS, t ex i den multinationella studien ENVIMS och studier av könskvot.
Publikationer
Senaste publikationer
- Characterization of the Increase in Narcolepsy following the 2009 H1N1 Pandemic in Sweden (2024)
- Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study (2024)
- Inventory study of an early pandemic COVID-19 cohort in South-Eastern Sweden, focusing on neurological manifestations (2023)
- A comprehensive diagnostic approach in suspected neurosarcoidosis (2023)
- Shift workers are at increased risk of severe COVID-19 compared with day workers (2023)
Alla publikationer
Artiklar
- Characterization of the Increase in Narcolepsy following the 2009 H1N1 Pandemic in Sweden (2024)
- Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study (2024)
- Inventory study of an early pandemic COVID-19 cohort in South-Eastern Sweden, focusing on neurological manifestations (2023)
- A comprehensive diagnostic approach in suspected neurosarcoidosis (2023)
- Shift workers are at increased risk of severe COVID-19 compared with day workers (2023)
- The association of insomnia with long COVID (2023)
- Case report (2023)
- The Importance of Optical Coherence Tomography in the Diagnosis of Atypical or Subclinical Optic Neuritis (2023)
- Absence of Oligoclonal Bands in Multiple Sclerosis (2023)
- Associations between changes in habitual sleep duration and lower self-rated health among COVID-19 survivors (2023)
- Sleep symptoms are essential features of long-COVID (2023)
- Sleep symptoms are essential features of long-COVID - Comparing healthy controls with COVID-19 cases of different severity in the international COVID sleep study (ICOSS-II) (2023)
- Association between hypersomnolence and the COVID-19 pandemic (2023)
- Persistent short nighttime sleep duration is associated with a greater post-COVID risk in fully mRNA-vaccinated individuals. (2023)
- Similar Profile and Magnitude of Cognitive Impairments in Focal and Generalized Epilepsy (2022)
- Fatal Acute Hemorrhagic Encephalomyelitis and Antiphospholipid Antibodies following SARS-CoV-2 Vaccination (2022)
- Kleine-Levin syndrome is associated with birth difficulties and genetic variants in the TRANK1 gene loci (2021)
- Multiple sclerosis and COVID-19 (2021)
- Immunocyte single cell analysis of vaccine-induced narcolepsy (2021)
- Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease (2021)
- Ecstatic and gelastic seizures related to the hypothalamus (2021)
- Validating the diagnosis of multiple sclerosis using Swedish administrative data in Värmland County (2021)
- Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis (2021)
- The cost-utility of pitolisant as narcolepsy treatment. (2020)
- Aniridia with PAX6 mutations and narcolepsy (2020)
- Ecstatic and gelastic seizures relate to the hypothalamus (2020)
- Inherited Ataxia and Intrathecal Baclofen for the Treatment of Spasticity and Painful Spasms (2019)
- Structural anomaly in the reticular formation in narcolepsy type 1, suggesting lower levels of neuromelanin (2019)
- Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival (2019)
- Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects (2019)
- RebiQoL (2019)
- Organic solvent exposure as a risk factor for multiple sclerosis (2019)
- Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden (2018)
- Increased risk of MS after organic solvent exposure (2018)
- A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of dimethyl fumarate (IMSE 5) (2018)
- A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of teriflunomid (IMSE 4) (2018)
- Neuroimaging in the Kleine-Levin Syndrome (2018)
- A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of fingolimod (IMSE 2) (2018)
- A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of alemtuzumab (IMSE 3) (2018)
- A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of natalizumab (IMSE 1) (2018)
- Unexpected Fat Distribution in Adolescents With Narcolepsy. (2018)
- Physical Activity Is Associated With A Decreased Multiple Sclerosis Risk (2018)
- Lifestyle factors and disease-specific differences in subgroups of Swedish Myasthenia Gravis (2018)
- Evidence for cognitive resource imbalance in adolescents with narcolepsy (2018)
- Cerebellar ataxia and intrathecal baclofen therapy (2017)
- Negative interaction between smoking and EBV in the risk of multiple sclerosis (2017)
- Patterns of antiepileptic drug prescription in Sweden (2017)
- Narcolepsy as a side effect of swine flu vaccination (2017)
- A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of dimethyl fumarate (IMSE 5) (2017)
- A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of teriflunomid (IMSE 4) (2017)
- Hereditary cerebellar ataxia and intrathecal baclofen (2017)
- A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of natalizumab (IMSE 1) (2017)
- RebiQoL (2017)
- The diagnosis of OCB-negative MS-patients - an inventory of the Swedish MS register in Uppsala, Sweden (2017)
- A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of fingolimod (IMSE 2) (2017)
- A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of alemtuzumab (IMSE 3) (2017)
- Tau or neurofilament light - Which is the more suitable biomarker for Huntington’s disease? (2017)
- Corpus callosum atrophy in MS is halted by autologous haematopoietic stem cell transplantation (2017)
- Rituximab in multiple sclerosis; data from the swedish MS registry. (2016)
- Adverse events of rituximab in a Swedish MS population sample. (2016)
- Altered Brain Microstate Dynamics in Adolescents with Narcolepsy (2016)
- New hypothesis on pontine-frontal eye field connectivity in Kleine-Levin syndrome (2016)
- Real world experience of fingolimod after switching multiple sclerosis (MS) therapy; focus on natalizumab naive and experienced persons with MS, respectively (2016)
- A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of dimethyl fumarate (IMSE 5) (2016)
- A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of natalizumab (IMSE 1) (2016)
- Extension of diffuse low-grade gliomas beyond radiological borders as shown by the coregistration of histopathological and magnetic resonance imaging data (2016)
- Prevalence and cost of epilepsy in Sweden - (2015)
- Does the changing sex ratio of multiple sclerosis give opportunities for intervention? (2015)
- Evidence of Conjoint Activation of the Anterior Insular and Cingulate Cortices during Effortful Tasks (2015)
- A Swedish nationwide pharmaco-epidemiological and genetic study (IMSE) of the long-term safety and efficacy of dimethyl fumarate (2015)
- Being parents with epilepsy (2015)
- Genetic load in eleven distantly related individuals from an MS high risk area (2015)
- A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and efficacy of natalizumab (2015)
- The IMSE 2 study (2015)
- Brain circuitries involved in sleep disorders (2015)
- The EnvIMS Study (2015)
- Antiepileptic drugs and intrauterine death (2015)
- Body size and the risk of multiple sclerosis in Norway and Italy (2015)
- Sun exposure and multiple sclerosis risk in Norway and Italy (2014)
- Regional variation in prevalence and healthcare utilization due to epilepsy in Sweden (2014)
- Age-specific sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg) (2014)
- Functional magnetic resonance imaging in narcolepsy and the Kleine-Levin syndrome (2014)
- Thalamic activation in the Kleine-Levin syndrome (2014)
- Reduced thalamic and pontine connectivity in kleine-levin syndrome (2014)
- Multi-parametric representation of voxel-based quantitative magnetic resonance imaging (2014)
- Epilepsy and violence (2014)
- Narkolepsi – ovanlig sjukdomsom fått ökad uppmärksamhet (2014)
- A Swedish nationwide pharmaco-epidemiological and genetic study (IMSE) of the long-term safety and efficacy of natalizumab (2014)
- The sleepy teenager (2014)
- Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; (2014)
- Psychosis in patients with narcolepsy as an adverse effect of sodium oxybate (2014)
- SPECT in the Kleine-Levin Syndrome, a Possible Diagnostic and Prognostic Aid? (2014)
- Effects of gadolinium contrast agent administration on automatic brain tissue classification of patients with multiple sclerosis (2014)
- Normal appearing and diffusely abnormal white matter in patients with multiple sclerosis assessed with quantitative MR (2014)
- New data identify an increasing sex ratio of multiple sclerosis in Sweden (2014)
- A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies (2014)
- Sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg) (2013)
- Thalamo-striato-cortical determinants to fatigue in multiple sclerosis (2013)
- Brain and effort (2013)
- Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue (2013)
- Impaired language function in generalized epilepsy (2013)
- Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans (2013)
- Low thalamic NAA-concentration corresponds to strong neural activation in working memory in Kleine-Levin syndrome (2013)
- Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in Sweden (2012)
- Bent spine syndrome (2012)
- Association between change in normal appearing white matter metabolites and intrathecal inflammation in natalizumab-treated multiple sclerosis (2012)
- A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q) (2012)
- CSF Proenkephalin decreases with the progression of Huntington's disease
- Cerebral blood flow in multiple sclerosis: an 15O-water PET study
- Lifestyle factors and gender-related differences in clinical subgroups of Myasthenia Gravis in southern Sweden
